California CRE News In Your Inbox.
Sign up for Connect emails to stay informed with CRE stories that are 150 words or less.
DivcoWest Signs Oncology Company in South San Francisco
IDEAYA Biosciences, a clinical-stage precision medicine oncology company, is coming to DivcoWest’s 5000 Shoreline Ct. The property is a 140,000-square-foot Class A building on the bay in South San Francisco’s Sierra Point life science cluster.
The long-term lease for 44,000 square feet was signed earlier this month and gives IDEAYA access to lab space designed specifically for its needs and growth plans. Move-in is expected in mid-2024.
DivcoWest was represented by Chris Jacobs and Matt Jacobs of CBRE. IDEAYA Biosciences was represented by Grant Dettmer and Scott Miller of JLL.
DivcoWest acquired 5000 Shoreline as a vacant office building last year and immediately put in place a plan to convert the waterfront property to high quality lab use, upgrading building systems and infrastructure to appeal to life science users.
- ◦Lease


